GS-0976 (Firsocostat): an investigational liver-directed acetyl-CoA carboxylase (ACC) inhibitor for the treatment of non-alcoholic steatohepatitis (NASH)

Naim Alkhouri, Eric Lawitz, Mazen Noureddin, Ralph DeFronzo, Gerald I. Shulman

Research output: Contribution to journal › Article › peer-review

106 Scopus citations

Fingerprint

Dive into the research topics of 'GS-0976 (Firsocostat): an investigational liver-directed acetyl-CoA carboxylase (ACC) inhibitor for the treatment of non-alcoholic steatohepatitis (NASH)'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science